Interplays between mouse mammary tumor virus and the cellular and humoral immune response.
Immunol Rev
; 168: 287-303, 1999 Apr.
Article
en En
| MEDLINE
| ID: mdl-10399081
Mouse mammary tumor virus has developed strategies to exploit the immune response. It requires vigorous immune stimulation to achieve efficient infection. The infected antigen-presenting cells present a viral superantigen on the cell surface which stimulates strong CD4-mediated T-cell help but CD8 T-cell responses are undetectable. Despite the high frequency of superantigen-reactive T cells, the superantigen-induced immune response is comparable to classical antigen responses in terms of T-cell priming, T-cell-B-cell collaboration as well as follicular and extra-follicular B-cell differentiation. Induction of systemic anergy is observed, similar to classical antigen responses where antigen is administered systemically but does not influence the role of the superantigen-reactive T cells in the maintenance of the chronic germinal center reaction. So far we have been unable to detect a cytotoxic T-cell response to mouse mammary tumor virus peptide antigens or to the superantigen. This might yet represent another step in the viral infection strategy.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones Tumorales por Virus
/
Virus del Tumor Mamario del Ratón
/
Infecciones por Retroviridae
/
Inmunidad Celular
/
Formación de Anticuerpos
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Immunol Rev
Año:
1999
Tipo del documento:
Article
País de afiliación:
Suiza
Pais de publicación:
Reino Unido